Kowa Company Limited

Sds Biotech K.k.

Showa Denko Kabushiki Kaisha

Honda Motor Co., Ltd.

Stanley Electric Co., Ltd

Tokyo University of Science Foundation

Yuki Yamaguchi

Kimiyuki Shibuya

Takayuki Matsuda

Ayumu Okuda

Sayaka Kurobuchi

Minoru Koura

Yuichiro Watanabe

Hiroshi Kubo

Takeshi Shibuya

Yukihiro Nakamura

Keijitsu Tanaka

Motoki Tanaka

Tetsuo Tsuruya

Nansho Seki

Eiji Ikuta

Kotaro Yoshinaga

Takashi Enomoto

Toru Miura

Koichi Yamazaki

Hisashi Sumida

Koji Matsumoto

Takanori Aimono

Go Ito

Hidefumi Ozawa

Keiichi Ikegami

Ayako Tosaka

Yuuichirou Watanabe

Keishi Nishio

Shinichi Uozumi

Masakazu Satsu

A vehicle is partitioned into a vehicle interior and a front room in front of a vehicle interior by a dash panel extending upward from a floor panel, an internal combustion engine is disposed in the front room, an exhaust pipe extends in a front-rear direction below the floor panel, a heat shielding member is disposed above the exhaust pipe so as to cross the exhaust pipe when viewed from an upper-lower direction, a plurality of heat exchangers fixed to a bracket are fixed to a lower side of the floor panel such that they are located behind the front room, above the heat shielding member, and at least partially overlap the heat shielding member when viewed from the upper-lower direction, and the heat shielding member is divided into a first heat shielding plate and a second heat shielding plate in the front-rear direction.

Control device and control method

Provided is a hydrogen concentration measuring device capable of measuring with high accuracy a hydrogen concentration over an extensive range by a simple configuration. The device includes: a sensor chip which detects the electric resistance of a sensing film; an optical measurement unit which detects the transmitted light intensity of the film; and a controller. The controller performs measurement processing such that a hydrogen concentration in the gas atmosphere is measured based on the detected electric resistance in a first measurement range and based on the detected transmitted light intensity in a second measurement range and is determined so as to reduce a difference between the hydrogen concentration based on the detected electric resistance and the hydrogen concentration based on the detected transmitted light intensity in the overlap of the first measurement range and the second measurement range.

Hydrogen concentration measuring device

An inhibitor for tobacco axillary bud growth, containing chlorthal-dimethyl and aliphatic alcohol selected from decyl alcohol, 2-ethyl hexanol and geraniol in combination; and a method for inhibiting tobacco axillary bud growth, which includes applying the inhibitor for tobacco axillary bud growth.

Tobacco axillary bud growth inhibitor and method for inhibiting tobacco axillary bud growth

An inhibitor for tobacco axillary bud growth, the inhibitor containing one or more cell division inhibitors selected from pyridine-based compounds and benzamide-based compounds. This inhibitor may further include an aliphatic alcohol having 6 to 20 carbon atoms in combination with the one or more cell division inhibitors.

Tobacco axillary bud inhibitor and tobacco axillary bud-inhibiting method

The present invention relates to an inhibitor for tobacco axillary bud growth, the inhibitor comprising, as an active ingredient, one or more kinds of very-long chain fatty acid synthesis inhibitors such as a chloroacetamide-based herbicide, fentrazamide, cafenstrole or indanofan; an inhibitor for tobacco axillary bud growth, the inhibitor comprising the aforesaid very-long chain fatty acid synthesis inhibitor together with clorthal-dimethyl or an aliphatic alcohol having 6 to 20 carbon atoms; and a method for inhibiting tobacco axillary bud growth which comprises applying the inhibitor for tobacco axillary bud growth. The inhibitor for tobacco axillary bud growth of the present invention shows sustained drug efficacy at a low concentration, induces neither chemical injury nor disease, and can contribute to the improvement in labor productivity.

Inhibitor for tobacco axillary bud growth and method for inhibiting tobacco axillary bud growth

There is provided a novel LXR&#x3b2; agonist useful as a preventative and/or therapeutic agent for arteriosclerosis; arteriosclerosis such as those resulting from diabetes; hyperlipidemia; hypercholesterolemia; lipid-related diseases; inflammatory diseases caused by inflammatory cytokines, skin diseases such as allergic skin diseases, diabetes or Alzheimer's disease. The agonist is a carbinol derivative represented by the following general formula (1) or salt thereof, or their solvate.

Substituted carbinol compound

[Object] To provide a novel LXR&#x3b2; agonist that is useful as a preventative and/or therapeutic agent for atherosclerosis; arteriosclerosis such as those resulting from diabetes; dyslipidemia; hypercholesterolemia; lipid-related diseases; inflammatory diseases that are caused by inflammatory cytokines; skin diseases such as allergic skin diseases; diabetes; or Alzheimer's disease. [Solving Means] A carbinol compound represented by the following general formula (I) or salt thereof, or their solvate. 

Carbinol derivatives having cyclic linker

To provide a novel LXR&#x3b2; agonist that is useful as a preventative and/or therapeutic agent for atherosclerosis; arteriosclerosis such as those resulting from diabetes; dyslipidemia; hypercholesterolemia; lipid-related diseases; inflammatory diseases that are caused by inflammatory cytokines; skin diseases such as allergic skin diseases; diabetes; or Alzheimer's disease. A quinoline compound represented by the following general formula (1) or salt thereof, or their solvate. 

Quinoline compounds

The object is to provide a novel LXR&#x3b2; agonist that is useful as a preventative and/or therapeutic agent for atherosclerosis; arteriosclerosis such as those resulting from diabetes; dyslipidemia; hypercholesterolemia; lipid-related diseases; inflammatory diseases that are caused by inflammatory cytokines; skin diseases such as allergic skin diseases; diabetes; or Alzheimer's disease. The solving means is a 1,3-dihydroisobenzofuran derivative represented by the following general formula (1) or salt thereof, or their solvate. 

1,3-dihydroisobenzofuran derivatives

To provide a novel LXR&#x3b2; agonist that is useful as a preventative and/or therapeutic agent for atherosclerosis; arteriosclerosis such as those resulting from diabetes; dyslipidemia; hypercholesterolemia; lipid-related diseases; inflammatory diseases that are caused by inflammatory cytokines; skin diseases such as allergic skin diseases; diabetes; or Alzheimer's disease. [Solving Means] A 2-oxochromene derivative represented by the following general formula (1) or salt thereof, or their solvate. 

2-oxochromene derivatives

A pyrazole derivative represented by the formula (I): ##STR1## wherein R.sup.1 and R.sup.2 each represents a lower alkyl group, which has herbicidal activity, is disclosed. A process for preparing the pyrazole derivative of the formula (I) is also disclosed. A herbicide containing as an active ingredient the pyrazole derivative of the formula (I) is further disclosed as is a method for using the herbicide.

Herbicidal N-(5-t-butyl-3-pyrazolyl) carbamates

A novel pyrazole derivative represented by the formula [I]: ##STR1## wherein X and Y are defined in the specification, which has a herbicidal activity, is disclosed. A process for preparing the pyrazole derivative of the formula [I] is also disclosed. A herbicide containing as an active ingredient the pyrazole derivative of the formula [I] is further disclosed.

Herbicidal 5-t-butyl-3-(N-alkanoylamino)pyrazoles

A novel pyrazole derivative represented by the formula [I]: ##STR1## wherein X and Y are defined in the specification, which has herbicidal activity, is disclosed. A process for preparing the pyrazole derivative of the formula [I] is also disclosed. A herbicide containing as an active ingredient the pyrazole derivative of the formula [I] is further disclosed as is a method for using the herbicide.

Growing community of inventors

Tokyo, Japan

Yuki Yamaguchi